Lassonde Industries (LAS-A) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Achieved 8.3% sales growth to $724 million in Q3 2025, with all business units contributing and strong support from the Summer Garden acquisition.
Operating profit rose nearly 23% year-over-year, driven by effective pricing, improved private label mix, and operational improvements from new production assets.
Adjusted EBITDA increased 24.7% to $86.4 million, and adjusted EPS reached a record $5.84, up 28.9% year-over-year.
Integration of Summer Garden and ramp-up of North Carolina production supported operational gains and cost structure improvements.
Construction of the New Jersey facility is on schedule, supporting network expansion and future growth.
Financial highlights
Q3 2025 sales: $723.9M (+8.3% YoY); gross profit: $197.6M (27.3% of sales), up 9.9% YoY; operating profit: $57.9M (+22.7% YoY).
Adjusted EBITDA: $86.4M (11.9% of sales), up 24.7% YoY; adjusted EPS: $5.84, up 28.9% YoY.
Operating cash flow was $118M, up from $87M last year; CAPEX totaled $35M in Q3 and $142M year-to-date.
Net debt reduced to $550M, with net debt to adjusted EBITDA ratio at 1.71x as of September 27, 2025.
Summer Garden contributed $48.1M in sales; EBITDA margin at 16% for Q3 and near 21% for nine months.
Outlook and guidance
Full-year 2025 sales expected to increase slightly above 10%, driven by Summer Garden, new marketing, and expanded chilled distribution.
Priorities include private label volume build-back in the U.S., innovation in Canada, and food service expansion.
2025 CAPEX expected up to 7% of sales, with major investments in New Jersey and North Carolina facilities.
Effective tax rate projected at 24.5% for 2025; working capital ratio expected near upper historical range.
Commodity costs (orange, apple, pineapple concentrates) expected to remain volatile; hedging policy in place to manage risk.
Latest events from Lassonde Industries
- Sales up 22.8%, adjusted EBITDA up 36.5%, with strong specialty food and beverage growth.LAS-A
Q1 20258 Jul 2026 - Record sales, board transition, U.S. expansion, and all proposals approved amid strong results.LAS-A
AGM 20258 Jul 2026 - Q2 profit and sales surged, with acquisitions and new capacity fueling strong H2 prospects.LAS-A
Q2 20248 Jul 2026 - Record 2025 sales and profit set the stage for ambitious growth and innovation in 2026.LAS-A
AGM 2026 presentation17 May 2026 - 2025 sales rose 12.8% to $2.9B, with profit and margin gains driving a $3B target for 2026.LAS-A
Corporate presentation14 May 2026 - Operating profit up 22% and shareholder profit up 50% despite lower sales.LAS-A
Q1 202611 May 2026 - Record sales and margin growth in 2024, with 10% sales growth targeted for 2025.LAS-A
Q4 202427 Apr 2026 - Strong 2025 sales and EBITDA growth driven by U.S. expansion, innovation, and acquisitions.LAS-A
Corporate presentation24 Apr 2026 - Record sales and profit growth in 2025 set the stage for a $3B sales target in 2026.LAS-A
Q4 20252 Apr 2026